Roflupram is a selective, orally active, brain-penetrant phosphodiesterase 4 (PDE4) inhibitor used in preclinical research to study neuroinflammation, cognitive function, and PDE4-mediated signaling. It is supplied as a high-purity research chemical with documented solubility and storage recommendations suitable for in vitro and in vivo use.
- Selective PDE4 inhibition with low nanomolar potency.
- Brain-penetrant, suitable for CNS studies.
- High purity appropriate for biochemical and cellular assays.
- Soluble in DMSO; in vivo formulation protocols available.
- Recommended storage conditions to maintain stability.